April 18, 2014

Statin Drugs Linked To Arthritis, Heart Trouble And More

statin 20drug 20arthritis 281 29 Statin Drugs Linked To Arthritis, Heart Trouble And More

by Sayer Ji
GreenMedInfo

Research revealing the broad spectrum toxicity of statin drugs continues to accumulate unabated.  A new study reveals that these cholesterol-lowering drugs may be contributing to an epidemic of arthritis and autoimmunity in exposed populations, adding to a growing body of clinical evidence that they may cause over 300 adverse health effects.

Published this month in the journal Arthritis Research & Therapy, and titled “Statins accelerate the onset of collagen type II-induced arthritis in mice,” researchers found that 100% of the animals given statin drugs developed arthritis and markers of autoimmunity versus 58% in the control population who did not receive them.[1]

The study was performed in the wake of an observational study showing that statin drug use was associated with an increased risk of developing rheumatoid arthritis.[2]  The researchers hypothesized that statin drug use may eventually lead to dysregulation of immune responses, possibly resulting in autoimmunity.  This finding does not come as a great surprise considering that statins have already been linked to lupus-like syndrome,[3] as well as immune-mediated necrotizing myopathy.[4]

Because atherosclerosis is known to have an autoimmune component, the emerging connection between statins and autoimmunity may undermine the justification for their continued use in the primary prevention of heart disease. Lesions form in an artery only after the body’s immune system snowballs out of control. White blood cells (macrophages and T-lymphoctyles) infiltrate the damaged area in an attempt to heal it, absorbing oxidized-LDL in the process, and eventually depositing in the artery wall as foam cells, triggering more white blood cells to infiltrate in a vicious cycle.

The blood work of heart disease patients has also shown elevations of a well-known marker of autoimmunity in the blood, namely, antinuclear antibodies.[5] What is more concerning is that statin drugs have been shown to induce elevations of these same antibodies,[6]not only calling into question their utility in preventing heart disease, but implicating them as potentially cardiotoxic agents.

Indeed, the cardiotoxicity of statin drugs was demonstrated back in 2009 when the journal of Clinical Cardiology showed that statin drugs actually weaken the heart muscle.[7] In addition, the GreenMedInfo.com statin drugs research page now contains 76 studies indicating the myotoxicity (muscle-damaging) effect of statins and 53 studies indicating their neurotoxicity (nerve-damaging). Since the heart is a highly innervated muscle, using them for “protecting” the heart is an insurmountable contradiction.

Related Links

Consumer Alert: 300+ Health Problems Linked To Statin Drugs

Coconut Water May Drive the Statin Drug Industry NUTS

Chocolate Gives Statins A $29 Billion Run For Their Money

Lower Your Cholesterol, Increase Your Diabetes Risk By 48%

Confirmed Once Again: Statins Likely Harm The Heart


[1] Statins accelerate the onset of collagen type II-induced arthritis in mice. Arthritis Res Ther. 2012 Apr 26 ;14(2):R90. Epub 2012 Apr 26. PMID: 22537858

[2] Use of statins is associated with an increased risk of rheumatoid arthritis. Ann Rheum Dis. 2011 Oct 6. Epub 2011 Oct 6. PMID: 21979000

[3] Association Between Statin Use and Lupus-Like Syndrome Using Spontaneous Reports. Semin Arthritis Rheum. 2011 Aug 23. Epub 2011 Aug 23. PMID: 21868063

[4] Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.Nat Rev Neurol. 2011 Jun ;7(6):343-54. Epub 2011 Jun 8. PMID: 21654717

[5] More Evidence that Atherosclerosis Is An Autoimmune Disease? http://www.theheart.org/article/166113.do

[6] [Polymyositis induced or associated with lipid-lowering drugs: five cases].Rev Med Interne. 2004 Apr ;25(4):294-8. PMID: 15050796

[7] Statin therapy decreases myocardial function as evaluated via strain imaging. Clin Cardiol. 2009 Dec;32(12):684-9. PMID: 20027659

Read the Full Article and Comment here: http://www.greenmedinfo.com/blog/statin-drugs-linked-arthritis-heart-trouble-and-more

0 commentsback to post

Other articlesgo to homepage

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

Congressman Bill Posey’s strong resolve and demands for transparency were evident as he discussed the Center for Disease Control (CDC)’s handling of vaccine safety studies which affect “our most precious resource in our nation – our children.” The 30-minute interview, conducted by vaccine industry watchdog, PhD biochemist Brian Hooker, delves into what Posey called “the incestuous relationship between the public health community and the vaccine makers and public officials.”

The Florida legislator, known as “Mr. Accountabililty,” did not mince words when criticizing current and past CDC officials including indicted fraudster Dr. Poul Thorsen; CDC director turned Merck Vaccine President Dr. Julie Gerberding; and the agency’s current spokesperson regarding autism and vaccines, Dr. Coleen Boyle.

Congressman Posey said, “The CDC can’t be trusted regarding investigating vaccine safety. Huge conflict of interest. I think the CDC should be investigated.”

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

In an interview with Dr. Bernard Dalbergue, a former pharmaceutical industry physician with Gardasil manufacturer Merck, he predicts that Gardasil will become the greatest medical scandal of all time. Dr. Dalbergue believes that at some point in time, the evidence will add up to prove that this vaccine, technical and scientific feat that it may be, has absolutely no effect on cervical cancer and that all the very many adverse effects which destroy lives and even kill young girls, serves no other purpose than to generate profit for the manufacturers.

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

An important new book by a recognized medical research expert describes Big Pharma as akin to the Mafia. In an interview conducted by our colleagues at ANH-Europe, Dr. Peter C. Gøtzsche exposes the flaws of the drug approval system, our reliance on dangerous drugs, and the deadly co-dependence between regulators and industry. Dr. Gøtzsche is co-founder of the highly respected Cochrane Collaboration and Cochrane Reviews, a leading journal of evidence-based medicine. The interview is particularly timely now that the FDA has decided to remove restrictions on the dangerous drug Avandia.

Dr. Gøtzsche’s new book, Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare, points out that the pharmaceutical industry is allowed to test their own drugs, and thus effectively be their own judge. He calls this a threat to safe medicine and asks for open access to all research data, including raw data, because otherwise, data can be easily suppressed and conclusions manipulated by industry.

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical marijuana, or cannabis, is legal in 20 US states, where it is used for a variety of medical conditions such as mood disorders, pain disorders, multiple sclerosis, and even cancer. Parents of children with epilepsy met at a news conference to share their dismay that Governor Mark Dayton refuses to legalize medical marijuana. About 85 percent to 95 percent of Americans are in favor of medical cannabis, and nearly 60 percent are in favor of legalizing marijuana. Cannabis shows outstanding promise as a medicinal plant, largely due to its cannabidiol (CBD) content. Cannabinoids interact with your body by way of naturally occurring cannabinoid receptors embedded in cell membranes throughout your body.

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Pharmaceutical company payments to doctors extend far beyond rank-and-file clinicians — and deep into the leadership of America’s teaching hospitals, according to a study published recently in the Journal of the American Medical Association.

A team of researchers at the University of Pittsburgh Medical Center examined the boards of the 50 largest drug companies by global sales (excluding three companies that were not publicly traded). The researchers found that 40 percent — 19 companies — had at least one board member who also held a leadership role at an academic medical center. Sixteen of the 17 companies based in the United States had at least one. Several had more than one. All told, the research team found that 41 of the companies’ 2012 board members held leadership positions at academic medical centers. Six of the 41 were pharmaceutical company executives who served on hospital boards of directors or held other leadership posts.

The authors wrote that when academic medical leaders serve on pharmaceutical company boards, it can lead to conflicts not only for individuals, but for the critically important health care institutions they guide.

read more


Get the news right in your inbox!